Central venous port devices are indicated for patients, who need long-term intravenous
therapy. Oncologic patients may require intermittent administration of chemotherapy …

Background Over the last decades, many changes have occurred in oncology with new
chemotherapy combinations and more complex application schemes becoming available …

Purpose To develop an evidence-based guideline on central venous catheter (CVC) care for
patients with cancer that addresses catheter type, insertion site, and placement as well as …

The subcutaneous venous access device (SVAD or “port”) is a critical component in the care
of patients with chronic disease. The modern SVAD provides reliable access for blood …

Background Invasive fungal infections, such as candidemia, caused by Candida species
have been increasing. Candidemia is not only associated with a high mortality (30% to 40%) …

Neutrophils play an important role in immunological function. Neutropenic patients are
vulnerable to infection, and except fever is present, inflammatory reactions are scarce in …

The objective of this review was to determine whether consistent definitions were used in
published studies of bloodstream infections due to central venous catheters in patients with …

PAGANINI, Hugo et al. Diagnóstico y tratamiento de la neutropenia febril en niños con
cáncer: Consenso de la Sociedad Latinoamericana de Infectología Pediátrica. Rev. chil …

Otherwise unexplained clinical signs of infection in patients with long-term tunnelled or
totally implanted central venous access devices (CVADs) are suspected to be CVAD …

The effect of micafungin dose scheduling on the treatment of candidemia is unknown.
Neutropenic mice with disseminated Candida glabrata infection were treated with single …